Record Quarterly Revenue
Third quarter total revenue increased 24% to $7.6 million, marking a quarterly revenue record for the company and the eighth consecutive quarter of exceeding guidance.
Strong System Placements
Placed 7 Growth Direct systems across North America, Europe, and Asia Pacific, marking the strongest placement quarter since Q3 2021.
Improved Gross Margins
Achieved a 35 percentage point improvement in gross margins year-over-year, resulting in positive 8% gross margins for the third quarter.
Positive Customer Engagement
Received a multisystem order from a top 20 pharma customer for a global rollout, highlighting the success of the land and expand commercial strategy.
Operational Efficiency
On track to achieve positive cash flow by the end of 2027 without additional financing, with ongoing efforts to reduce product costs and enhance manufacturing efficiencies.